Substitution of a conserved amino acid residue alters the ligand binding properties of peroxisome proliferator activated receptors

被引:8
作者
Causevic, M
Wolf, CR
Palmer, CNA [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Ninewells Hosp & Med Sch, Imperial Canc Res Fund, Mol Pharmacol Unit, Dundee DD1 9SY, Scotland
基金
英国生物技术与生命科学研究理事会;
关键词
nuclear receptor; peroxisome proliferator; fatty acid; fluorescence; thiazolidinedione; diabetes;
D O I
10.1016/S0014-5793(99)01618-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutation of glutamic acid 282 of PPAR alpha to glycine has been shown to result in an increased EC50 for a wide variety of PPAR activating compounds. This has suggested that mutant receptor has a reduced ability to bind ligand. In this study we show that this mutation reduces the affinity of mPPAR alpha and hPPAR gamma for the fluorescent fatty acid, cis-parinaric acid and that the mutant hPPAR gamma protein has:a reduced affinity for the radiolabelled compound, SB236636. These data confirm the role of this glutamic acid in ligand binding and support recent crystal structure observations regarding a proposed novel mode of ligand entry into the PPAR ligand binding cavities. (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:205 / 210
页数:6
相关论文
共 30 条
  • [1] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [2] Induction of cytochrome P-450(BM-3) (CYP 102) by non-steroidal anti-inflammatory drugs in Bacillus megaterium
    English, N
    Hughes, V
    Wolf, GR
    [J]. BIOCHEMICAL JOURNAL, 1996, 316 : 279 - 283
  • [3] Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta
    Forman, BM
    Chen, J
    Evans, RM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (09) : 4312 - 4317
  • [4] 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA
    FORMAN, BM
    TONTONOZ, P
    CHEN, J
    BRUN, RP
    SPIEGELMAN, BM
    EVANS, RM
    [J]. CELL, 1995, 83 (05) : 803 - 812
  • [5] HSU MH, 1995, MOL PHARMACOL, V48, P559
  • [6] ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0
  • [7] PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
    Jiang, CY
    Ting, AT
    Seed, B
    [J]. NATURE, 1998, 391 (6662) : 82 - 86
  • [8] Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting
    Kersten, S
    Seydoux, J
    Peters, JM
    Gonzalez, FJ
    Desvergne, B
    Wrahli, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (11) : 1489 - 1498
  • [9] A PROSTAGLANDIN J(2) METABOLITE BINDS PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AND PROMOTES ADIPOCYTE DIFFERENTIATION
    KLIEWER, SA
    LENHARD, JM
    WILLSON, TM
    PATEL, I
    MORRIS, DC
    LEHMANN, JM
    [J]. CELL, 1995, 83 (05) : 813 - 819
  • [10] LEE SST, 1995, MOL CELL BIOL, V15, P3012